

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hot flashes | D019584 | — | — | 1 | 2 | — | — | — | 3 |
| Pain | D010146 | EFO_0003843 | R52 | — | 2 | — | — | — | 2 |
| Peripheral nervous system diseases | D010523 | — | G64 | — | 2 | — | — | — | 2 |
| Diabetic neuropathies | D003929 | EFO_1000783 | — | — | 2 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 5 | — | — | — | — | 5 |
| Drug common name | ELISMETREP |
| INN | elismetrep |
| Description | Elismetrep is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target transient receptor potential cation channel subfamily M member 8. |
| Classification | Small molecule |
| Drug class | antagonists of the transient receptor potential channel (TRP), melatsatin (TRPM) type; transient receptor potential antagonists |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | O=C(O)c1ccc(S(=O)(=O)N(Cc2ccc(OC(F)(F)F)cc2)c2ncc3ccccc3c2C2CC2)cc1 |
| PDB | — |
| CAS-ID | 1400699-64-0 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3682589 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | KIB8V5UR7D (ChemIDplus, GSRS) |
